Neuropeptide analogue research

Semax

ACTH(4-10)-derived heptapeptide studied in neurotrophic and gene-expression models.

Explore presentation-specific analytical records covering identity, purity, measured content, lot traceability and downloadable Certificates of Analysis.

Certified presentations
Product information
Royal Pharma Semax vial
Selected record5 mg

Product-family image supplied by Royal Pharma. Certified presentations are identified by their individual COA records below.

Product authentication

Authenticity, built into every product.

Powered by NFC. Secured by blockchain. Verified instantly.

Each Royal Pharma product carries a unique NFC-enabled microchip connected to the brand's proprietary blockchain authentication environment, creating a secure, traceable and tamper-resistant digital identity.

01
Unique identity

A product-linked NFC identity designed for one-tap verification.

02
Secure verification

A blockchain-secured record supporting authenticity and traceability.

03
Batch documentation

Presentation-specific COAs document identity, purity, measured content and lot information.

Product information

Neuropeptide analogue research, documented by batch.

Semax is a seven-amino-acid synthetic analogue derived from the ACTH(4-10) fragment with a Pro-Gly-Pro extension. Research examines neurotrophic signalling and gene-expression endpoints; Royal Pharma analytical records are presented by strength below.

01

Research class

ACTH(4-10)-derived synthetic heptapeptide
02

Documentation status

Investigational research compound
03

Reference CAS

80714-61-0
04

Physical form

White lyophilised powder

Research profile

An ACTH fragment redesigned for neural research.

Laboratory literature characterises Semax in BDNF-related, melanocortin and cerebral-stress models. These research observations do not establish clinical use for the supplied samples.

7 AA
ACTH-derived sequence

The core sequence originates from the ACTH(4-10) fragment.

ACTH
Pro-Gly-Pro extension

The stabilising extension differentiates the analogue from its parent fragment.

BDNF
Neurotrophic models

Research examines BDNF expression and related signalling under experimental conditions.

Quality documentation

Certificate of Analysis

Choose a presentation to display the exact analytical record
supplied for that sample.

Select presentation
Selected COA

Semax · 5 mg

Purity99.813%
Measured content
5.14 mg
Identity
Semax
Lot
001-11-2025
Appearance
White Lyophilized Powder
Accession number
2607061924
Search code
Received
03/05/2026
Reported
3/07/2026
For laboratory research use only.

The supplied certificates state that the tested materials are intended for research use only and are not approved for human or veterinary use, diagnostic, therapeutic or clinical applications. Results are specific to the submitted samples. This page does not provide medical advice, dosing or administration instructions.